Predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab

OBJECTIVE: This study was performed to investigate the proportion as well as the predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab (PCH). RESULTS: The pCR rate in the brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jinhua, Yang, Yinlong, Jiang, Li, Wu, Weizhu, Shao, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593588/
https://www.ncbi.nlm.nih.gov/pubmed/28915617
http://dx.doi.org/10.18632/oncotarget.17993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593588/
https://www.ncbi.nlm.nih.gov/pubmed/28915617
http://dx.doi.org/10.18632/oncotarget.17993

Ejemplares similares